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Cyberdrugs: a cross-sectional study of online
pharmacies characteristics
Grazia Orizio1, Peter Schulz2, Serena Domenighini1, Luigi Caimi3,
Cristina Rosati1, Sara Rubinelli2, Umberto Gelatti1
As e-commerce and online pharmacies (OPs) arose, the potential impact of the Internet on the world of
health shifted from merely the spread of information to a real opportunity to acquire health services
directly. Aim of the study was to investigate the offer of prescription drugs in OPs, analysing their
characteristics, using the content analysis method. The research performed using the Google search
engine led to an analysis of 118 online pharmacies. Only 51 (43.2%) of them stated their precise
location. Ninety-six (81.4%) online pharmacies did not require a medical prescription from the
customer’s physician. Online pharmacies rise complex issues in terms of patient–doctor relationship,
consumer empowerment, drug quality, regulation and public health implications.
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Introduction
Online pharmacies (OPs) are companies which sell drugs,including prescription-only drugs, through the Internet.
This phenomenon started in the late nineties1 and has grown
so much that the United States Food and Drug Administration
(FDA) defines it as a ‘serious public health risk’, when it
becomes ‘the sale of unapproved drugs and the illegal sale
of approved drugs over the Internet’.2 The World Health
Organization (WHO) faces this issue in the context of coun-
terfeit medicines, which are defined as ‘a global public health
crisis’, stating that ‘medicines purchased over the Internet
from sites that conceal their physical address are counterfeit in
over 50% of cases’.3 In this context, it is very difficult to
estimate the number of people buying online, the volume
of drugs traded and the economic extent of this business.4
Anyway, the risk represented by a free market of prescription
drugs which transforms patients into consumers is clearly
exemplified by some clinical cases arising in association with
medication purchased via the Internet,5 and by surveys in
which researchers successfully purchased prescription medica-
tions by the internet.6 Until now, e-commerce of drugs does
not yet seem to have spread much in Europe, but the Sentence
of the EU Court of Justice related to the ‘Doc Morris case’
shows how living the matter can quickly become.1,7 In order to
investigate the offer of online prescription drugs, we conducted
a survey of OPs using a search engine and we analysed the
characteristics of the websites found, focusing in particular
on the geographical features of the companies, on their
prescription requirements and promotion strategies, on the
kind of drugs offered and the declaration of side effects.
Methods
The search for OPs was conducted in August 2007 using the
Google search engine and the entire web was searched using as
keywords ‘online pharmacies’, ‘online drugstore’, ‘drugs
online’ and ‘medicines online’, according to the methodology
of previous OPs investigations.8 The first 30 references were
analysed for each keyword. The inclusion language was at
least English, and the sampling frame comprised only OPs
selling directly. The OPs websites were coded using an ad hoc
Codebook, according to the Content Analysis method,9 about
address, extension, prescription requirements and selling
arguments. We investigated whether the OPs gave a detailed
physical location with a clear geographical reference or had
only a virtual interface. We examined the offer of prescription
drugs, in particular of specific drugs with a high intrinsic risk
of being dangerous or inappropriate: tramadol, alprazolam,
amitriptyline, amphetamine or metamphetamine, codeine
or hydrocodone, fluxetine, methylphenidate, phentermine,
sidenafil, stanozolol, tramadol and valproic acid. An analysis
of the declared side effects was conducted on the four most
frequent drugs present in the OPs among the tracked ones
listed above. The data were analysed with STATA (Stata
Statistical Software Release 8.0, 2003; Stata Corporation,
College Station, TX) using a descriptive approach and
calculating statistical significance using the 2 test, the Fisher
exact test and the Mann–Whitney test, rejecting the null
hypothesis below a P-value of 0.05.
Results
We found 118 websites fitting the inclusion criteria, of which
51 (43.2%) with a specific address and 67 (56.8%) with a
virtual interface only. The most frequent website extension was
‘.com’, in 91 OPs (77.1%). Domains of registration were
distributed as follows in the world areas: 60 (50.9%) in the
United States, 26 (22.0%) in Europe, 11 (9.3%) in Canada and
15 (12.7%) in other countries; for six websites (5.0%) it was
not possible to ascertain domain registration. Fifty-one
(43.2%) of the OPs gave full details of the physical location:
18 stated they were in the United States (35.3%), 18 in Europe
(35.3%), 10 in Canada (19.6%) and five elsewhere (9.8%).
Only in the 54.9% of OPs declaring their physical location, the
latter corresponded to the area of domain registration.
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Forty-nine (41.5%) OPs declared the location of drug delivery,
which was mostly Asia (23 OPs, 46.9%), followed by the
United States (12 OPs, 24.5%). Agreement between declared
physical location and delivery location was found in 31.4% of
OPs proving both details.
Regarding prescription requirement, 22 (18.6%) OPs asked
for a medical prescription (prescription online pharmacies,
POPs), made out by the consumer’s physician. The remaining
96 OPs (81.4%) did not ask for a medical prescription
(non-prescription online pharmacies, nPOPs); of these, 30
(31.6%) did not ask for any kind of medical information,
whereas 66 (68.8%) required the consumer to fill in a medical
questionnaire. POPs declared their physical location more
often (72.7%) compared with nPOPs (36.5%), with a
statistically significant difference (Fisher exact test: p = 0.003).
An analysis of the sales promotion strategies revealed that
the most frequent were the safe use of personal data, short
delivery times, high drug quality, and the suggestion to buy
more to pay less. The selling argument regarding not having to
undergo a doctor’s examination and avoiding costs, queues
and embarrassment was present in 72.9% of nPOPs. We
compared the use of selling arguments in POPs and nPOPs,
and we found more present in nPOPs than in POPs with a
statistically significant difference the selling arguments about
discreet packaging, the suggestion to buy more to pay less, and
the promotion of a affiliation policy; free shipping policy was
performed more frequently in POPs (figure 1).
When we investigated the drugs that we chose for tracking
wideness of offering, on the 118 websites all of them were
available both in POPs and nPOPs; most frequently we found
sidenafil, fluoxetine, tramadol and amitriptyline.
In about one-fourth of OPs, no side effects were declared for
the four most frequently sold tracked drugs. The number of
declared side effects was significantly higher in nPOPs than in
POPs for fluoxetine and amitriptyline and not significantly for
tramadol, whereas the number of side effects for sidenafil was
significantly lower in nPOPs than in POPs (Mann–Whitney
test).
Discussion
This results show that more than half of the OPs did not
declared their physical location, and a great discordance was
detected between domain of registration, compared with
physical and delivery location, when declared. More than
80% of the OPs did not asked for a medical prescription, made
out by the consumer’s physician, in order to purchase drugs.
Many selling arguments were used to promote drugs, included
non having to see a doctor in order to access drugs. One forth
of OPs did not declared any side effect.
There are no doubts that the Internet—through its world-
wide network of computers allowing the global sharing of
information—has changed several aspects of our lives. In 1999,
health information was already being reported as among the
top three reasons why people use the web.10 But the big issue
which is arising now is that it is no longer merely a question of
information and knowledge: patients can now use the Internet
to purchase health services directly, i.e. drugs, medical devices
and medical tests.
About drugs, the chance to avoid prescription boundaries
can be a potential disruptor at multiple levels, both at an
individual level, between doctor and patient, becoming an
easy way to overcome the health professional filter in order
to access drugs,11 and at a public health level, where national
health services can be influenced by mixed accesses in
regulated systems.1
Besides, the characteristics of OPs could be associated with
the quality of the drugs and service. Indeed, there have been
reports of concern regarding the drugs storage and shipping
conditions, fraudulent and dangerous practices.11
As a final consideration, thinking about the reasons that
could lead a European citizen to purchase drugs from OPs,
it could be hypothesised that the opportunity to avoid doctors
and safeguard privacy are the main reasons, instead of
economic ones for people who live in a regulated drugs
market where final drugs prices are negotiated.
Conclusion
In conclusion, OPs are likely to become an important public
health issue in the near future, as they are growing in volume
and controversy.12 The fairly strict controls on the sale of drugs
which health authorities have successfully implemented
since the late 1990s can now be avoided quite easily through
e-commerce, which takes place in a globalized world with
virtually no barriers, and legislation seems to be late in
regulating this complex and dynamic issue.
In our opinion, the problem should be studied and
addressed on different levels: from the regulation point of
view, by increasing control and facing the legal issues; from the
public health point of view, by increasing awareness about
the risks associated with buying drugs on the Internet and
reinforcing the trust-based relationship between patient and
both the Pharmacist and the General Practitioner.
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Figure 1 Number of selling arguments present on the sample
frame of the 118 online pharmacies
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Key points
 A cross-sectional study was performed on websites
selling drugs, analysing 118 online pharmacies, and we
found that the majority of them did not ask for a
medical prescription, made out by the consumer’s
physician, in order to purchase prescription drugs.
 Numerous selling arguments were present to promote
drugs selling, in particular about the chance to
purchase prescription medications without prescrip-
tion and avoiding to see a doctor.
 Direct access to drugs through the internet rises
complex issues in terms of patient–doctor and
patient–pharmacist relationship, drug quality, health
policy, still to be faced both at a national and at an
international level.
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